FAK competes for Src to promote migration against invasion in melanoma cells

Cell Death and Disease

Volumn 5, Issue 8, 2014, Pages

  Kolli Bouhafs, K ^a,b   Sick, E ^a,b   Noulet, F ^a,b   Gies, J P ^a,b   De Mey, J ^a,b   Ronde P ^a,b  

^a Faculté de Pharmacie   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; FISH PROTEIN, MOUSE; FOCAL ADHESION KINASE 1; METALLOPORPHYRIN; MN(III) 5,10,15,20-TETRAKIS(N-METHYLPYRIDINIUM-2-YL)PORPHYRIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; PTK2 PROTEIN, MOUSE; PYRIMIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; DRUG EFFECTS; GENETICS; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION KINASE 1; MELANOMA; METALLOPORPHYRINS; MICE; PHOSPHOPROTEINS; PHOSPHORYLATION; PYRIMIDINES; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SRC-FAMILY KINASES;

EID: 84906848466     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.329     Document Type: Article

References (53)

1. Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A et al. Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol 2006; 85: 1217-1231.
2. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007; 67: 4227-4235.
3. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006; 66: 3034-3043.
4. Mueller SC, Chen WT. Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J Cell Sci 1991; 99(Pt 2): 213-225.
5. Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ et al. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 1999; 81: 774-782.
6. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 2000; 191: 245-256.
7. Kurschat P, Wickenhauser C, Groth W, Krieg T, Mauch C. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J Pathol 2002; 197: 179-187.
8. Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 2003; 13: 376-385.
9. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004; 5: 647-657.
10. Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008; 265: 157-166.
11. Courtneidge SA, Azucena EF, Pass I, Seals DF, Tesfay L. The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion. Cold Spring Harb Symp Quant Biol 2005; 70: 167-171.
12. Roskoski R Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004; 324: 1155-1164.
13. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, Courtneidge SA. Tks5-dependent nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2009; 2: ra53.
14. Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 2009; 122(Pt 17): 3037-3049.
15. Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat Cell Biol 2007; 9: 858-867.
16. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56-68.
17. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992; 89: 5192-5196.
18. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005; 5: 505-515.
19. Maung K, Easty DJ, Hill SP, Bennett DC. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 1999; 18: 6824-6828.
20. Hess AR, Hendrix MJ. Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle 2006; 5: 478-480.
21. Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 2005; 65: 9851-9860.
22. Saltel F, Chabadel A, Bonnelye E, Jurdic P. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol 2008; 87: 459-468.
23. Liu JD, Chen SH, Lin CL, Tsai SH, Liang YC. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J Cell Biochem 2001; 83: 631-642.
24. Hamadi A, Deramaudt TB, Takeda K, Ronde P. Src activation and translocation from focal adhesions to membrane ruffles contribute to formation of new adhesion sites. Cell Mol Life Sci 2009; 66: 324-338.
25. Ahmed S. Nanoscopy of cell architecture: the actin-membrane interface. Bioarchitecture 2011; 1: 32-38.
26. Stylli SS, Stacey TT, Verhagen AM, Xu SS, Pass I, Courtneidge SA et al. Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. J Cell Sci 2009; 122(Pt 15): 2727-2740.
27. Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, Woodrow M et al. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the proteasedriven invasion of cancer cells. Cancer Cell 2005; 7: 155-165.
28. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007; 445: 851-857.
29. Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355: 51-65.
30. Destaing O, Block MR, Planus E, Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 2011; 23: 597-606.
31. Murphy DA, Courtneidge SA. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011; 12: 413-426.
32. Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tete S, Luini A et al. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 2008; 121(Pt 3): 369-378.
33. Oikawa T, Oyama M, Kozuka-Hata H, Uehara S, Udagawa N, Saya H et al. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J Cell Biol 2012; 197: 553-568.
34. Schaller MD. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci 2010; 123(Pt 7): 1007-1013.
35. Hauck CR, Hsia DA, Ilic D, Schlaepfer DD. v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J Biol Chem 2002; 277: 12487-12490.
36. Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM et al. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 2006; 312: 1240-1253.
37. Bharti S, Inoue H, Bharti K, Hirsch DS, Nie Z, Yoon HY et al. Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol 2007; 27: 8271-8283.
38. Gianni D, Taulet N, DerMardirossian C, Bokoch GM. c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells. Mol Biol Cell 2010; 21: 4287-4298.
39. Gianni D, DerMardirossian C, Bokoch GM. Direct interaction between Tks proteins and the N-terminal proline-rich region (PRR) of NoxA1 mediates Nox1-dependent ROS generation. Eur J Cell Biol 2011; 90: 164-171.
40. Alexander NR, Branch KM, Parekh A, Clark ES, Iwueke IC, Guelcher SA et al. Extracellular matrix rigidity promotes invadopodia activity. Curr Biol 2008; 18: 1295-1299.
41. Chan KT, Cortesio CL, Huttenlocher A. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 2009; 185: 357-370.
42. Pan YR, Chen CL, Chen HC. FAK is required for the assembly of podosome rosettes. J Cell Biol 2011; 195: 113-129.
43. Wang Y, McNiven MA. Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol 2012; 196: 375-385.
44. Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr Biol 2003; 13: 1442-1450.
45. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004; 6: 154-161.
46. Deramaudt TB, Dujardin D, Hamadi A, Noulet F, Kolli K, De Mey J et al. FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol Biol Cell 2011; 22: 964-975.
47. Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008; 68: 650-656.
48. Widmer DS, Hoek KS, Cheng PF, Eichhoff OM, Biedermann T, Raaijmakers MI et al. Hypoxia contributes to melanoma heterogeneity by triggering HIF1alpha-dependent phenotype switching. J Invest Dermatol 2013; 133: 2436-2443.
49. Hoshino D, Jourquin J, Emmons SW, Miller T, Goldgof M, Costello K et al. Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCalpha invasive signaling axis. Sci Signal 2012; 5: ra66.
50. Timpson P, Jones GE, Frame MC, Brunton VG. Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol 2001; 11: 1836-1846.
51. Le Devedec SE, Geverts B, e Bont H, Yan K, Verbeek FJ, Houtsmuller AB et al. The residence time of focal adhesion kinase (FAK) and paxillin at focal adhesions in renal epithelial cells is determined by adhesion size, strength and life cycle status. J Cell Sci 2012; 125(Pt 19): 4498-4506.
52. Deramaudt TB, Dujardin D, Noulet F, Martin S, Vauchelles R, Takeda K et al. Altering FAKpaxillin interactions reduces adhesion, migration and invasion processes. PLoS One 2014; 9: e92059.
53. Artym VV, Yamada KM, Mueller SC. ECM degradation assays for analyzing local cell invasion. Methods Mol Biol 2009; 522: 211-219.